# Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma

> **NCT03275818** · PHASE2 · COMPLETED · sponsor: **Grupo Espanol de Investigacion en Sarcomas** · enrollment: 69 (actual)

## Conditions studied

- Tumor, Desmoplastic Small Round Cell, Adult
- Tumor, Desmoplastic Small Round Cell, Childhood
- Sarcoma, Ewing
- Sarcoma
- Desmoid

## Interventions

- **DRUG:** nab paclitaxel

## Key facts

- **NCT ID:** NCT03275818
- **Lead sponsor:** Grupo Espanol de Investigacion en Sarcomas
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-09
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-09-30
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2022-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03275818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03275818, "Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03275818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*